101 related articles for article (PubMed ID: 20541691)
21. Drug eruptions: approaching the diagnosis of drug-induced skin diseases.
Nigen S; Knowles SR; Shear NH
J Drugs Dermatol; 2003 Jun; 2(3):278-99. PubMed ID: 12848112
[TBL] [Abstract][Full Text] [Related]
22. [The use of skin testing in the investigation of toxidermia: from pathophysiology to the results of skin testing].
Barbaud A
Therapie; 2002; 57(3):258-62. PubMed ID: 12422538
[TBL] [Abstract][Full Text] [Related]
23. Approach to the patient with drug allergy.
Schnyder B
Med Clin North Am; 2010 Jul; 94(4):665-79, xv. PubMed ID: 20609856
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous reactions to anticonvulsant medications.
Hebert AA; Ralston JP
J Clin Psychiatry; 2001; 62 Suppl 14():22-6. PubMed ID: 11469671
[TBL] [Abstract][Full Text] [Related]
25. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
[TBL] [Abstract][Full Text] [Related]
26. Recognition and management of severe cutaneous drug reactions.
Knowles SR; Shear NH
Dermatol Clin; 2007 Apr; 25(2):245-53, viii. PubMed ID: 17430761
[TBL] [Abstract][Full Text] [Related]
27. Oral manifestations of adverse drug reactions: guidelines.
Femiano F; Lanza A; Buonaiuto C; Gombos F; Rullo R; Festa V; Cirillo N
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):681-91. PubMed ID: 18331319
[TBL] [Abstract][Full Text] [Related]
28. [Glycopeptide-induced cutaneous adverse reaction: results of an immunoallergic investigation in eight patients].
Perrin-Lamarre A; Petitpain N; Trechot P; Cuny JF; Schmutz JL; Barbaud A
Ann Dermatol Venereol; 2010 Feb; 137(2):101-5. PubMed ID: 20171430
[TBL] [Abstract][Full Text] [Related]
29. Clindamycin skin testing has limited diagnostic potential.
Notman MJ; Phillips EJ; Knowles SR; Weber EA; Shear NH
Contact Dermatitis; 2005 Dec; 53(6):335-8. PubMed ID: 16364122
[TBL] [Abstract][Full Text] [Related]
30. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
31. An approach to the evaluation and documentation of adverse drug reaction.
Goh CL
Singapore Med J; 1989 Jun; 30(3):285-9. PubMed ID: 2531469
[TBL] [Abstract][Full Text] [Related]
32. [Macrophage migration inhibition factor as a diagnostic aid in drug eruptions].
Halevy S; Grunwald MH; Sandbank M; Buimovice B; Livni E
Harefuah; 1991 Sep; 121(5-6):147-9. PubMed ID: 1834535
[TBL] [Abstract][Full Text] [Related]
33. Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts.
Speeckaert MM; Speeckaert R; Lambert J; Brochez L
Eur J Dermatol; 2010; 20(4):425-33. PubMed ID: 20542841
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities.
Callot V; Roujeau JC; Bagot M; Wechsler J; Chosidow O; Souteyrand P; Morel P; Dubertret L; Avril MF; Revuz J
Arch Dermatol; 1996 Nov; 132(11):1315-21. PubMed ID: 8915309
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous adverse drug reactions during chemotherapy: consider non-antineoplastic drugs.
Bursztejn AC; Tréchot P; Cuny JF; Schmutz JL; Barbaud A
Contact Dermatitis; 2008 Jun; 58(6):365-8. PubMed ID: 18503688
[TBL] [Abstract][Full Text] [Related]
36. [Cutaneous drug reactions: diagnosis and etiology].
Bonnetblanc JM; Nouaille Y
Rev Prat; 2000 Jun; 50(12):1300-4. PubMed ID: 10972069
[TBL] [Abstract][Full Text] [Related]
37. Skin testing for IgE-mediated drug allergy.
Kränke B; Aberer W
Immunol Allergy Clin North Am; 2009 Aug; 29(3):503-16. PubMed ID: 19563994
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous adverse drug reactions in a hospital setting.
Rademaker M; Oakley A; Duffill MB
N Z Med J; 1995 May; 108(999):165-6. PubMed ID: 7753511
[TBL] [Abstract][Full Text] [Related]
39. [Traditional and innovative diagnostic tools: when and why they should be applied].
Cancrini G; Iori A
Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
[TBL] [Abstract][Full Text] [Related]
40. Life-threatening acute adverse cutaneous drug reactions.
Wolf R; Orion E; Marcos B; Matz H
Clin Dermatol; 2005; 23(2):171-81. PubMed ID: 15802211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
